Skip to content

   
Welcome to AstraZeneca's international website. As one of the world's leading pharmaceutical companies, our business is focused on turning good ideas into innovative, effective medicines that make a real difference in important areas of healthcare.
Latest news
> 23 July 2008 : AstraZeneca and Bristol-Myers Squibb Submit New Drug Application in the United States and Marketing Authorisation Application in Europe for ONGLYZA™ (Saxagliptin) for the Treatment of Type 2 Diabetes
> 2 July 2008 : Summary Judgment Granted for SEROQUEL Patent Litigation in the US
> 26 June 2008 : AstraZeneca Announces Senior Management Changes at Biologics Business Unit, MedImmune
Features
> Second quarter and half year results will be announced on Thursday, 31 July 2008.
Read more about our new Code of Conduct, which reflects our continued commitment to doing business the right way.
AstraZeneca websites
Search
Quick links
Information for
US visitors
Share price
> London
> New York
> Stockholm
AstraZeneca news feed
Results announcement
 Terms of use  Privacy policy    © AstraZeneca PLC 2003 - 2008